Safety, Tolerability and Efficacy of ISIS-GCGRRx in Type 2 Diabetes
Clinical trial NCT01885260 · COMPLETED
Trial details
- NCT number
- NCT01885260
- Sponsor
- Ionis Pharmaceuticals, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2013-07-01
- Primary completion
- 2014-05-01
- Enrollment
- 77
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.